Clinipace implements eTMF solutions from TransPerfect

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/BrianAJackson)
(Image: Getty/BrianAJackson)

Related tags: Clinipace, Research, Software, CRO, Clinical research

Clinipace taps TransPerfect for interactive trial solutions to develop a responsive infrastructure for clinical research.

TransPerfect Life Sciences’ electronic feasibility and electronic trial master file (TMF) solutions were selected by the contract research organization (CRO) Clinipace as the company aims to create a flexible infrastructure to support clinical research.

The Trial Interactive eClinical platform offers an integrated suite of solutions to improve speed and site identification and selection, personnel training, study start-up, and site activation.

Trial Interactive will provide Clinipace with a web-based platform for clinical development to update clinical trial documentation online while maintaining global regulatory requirements. TransPerfect's trial solutions are currently used across 4,000 global organizations.

Michael Townley, chief information officer at Clinipace said in a statement that the CRO chose Trial Interactive as it offered “the intuitive interface, transparency, hosting, support, and validation that was essential.”

Agility Clinical​ in implemented Trial Interactive in an aim to go paperless. In that partnership, the eTMF system enabled the CRO to have real-time access to study documents and a cloud-based system. 

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars